Revenio Group Oyj — Share Issue/Capital Change 2021

Jun 15, 2021

Revenio Group Corporation: Increased number of shares entered into trade register

Revenio Group Corporation: Increased number of shares entered into trade register

Revenio Group Corporation, Stock Exchange Release, June 15, 2021 at 9:00

INCREASED NUMBER OF SHARES ENTERED INTO TRADE REGISTER

Total of 5,829 new share subscriptions based on the company’s 2015C stock options approved by the Board of Directors of Revenio Group Corporation on June 7, 2021, have been entered into the trade register today. The share subscription price under 2015C option rights was 12.48 EUR per share. The subscription period for 2015C options was May 31, 2019 – May 31, 2021.

After these subscriptions, the number of Revenio Group Corporation's shares and votes will rise to 26,681,116. The subscription price of the shares is recorded in their entirety in the reserve for invested unrestricted equity.

Revenio Group Corporation has applied for the listing of its new shares on the Nasdaq Helsinki in the same series as the company's existing shares. According to the current estimate, the new shares will be listed on June 16, 2021.

Revenio Group Corporation

Board of Directors

For further information, please contact:

---

CFO Robin Pulkkinen, tel. +358 50 505 9932

robin.pulkkinen@revenio.fi

www.revenio.fi

Revenio Group in brief

---

Revenio is a global leader in ophthalmological devices and solutions. Revenio Group's ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), retinal imaging devices, and perimeters under the iCare brand. In addition, Revenio Group’s eye care software platform Oculo combines clinical communication, telehealth, remote patient monitoring and data-analytics capabilities.

The Revenio Group comprises Revenio Group Corporation, Icare Finland Oy, Icare USA Inc., Revenio Italy S. R. L, CenterVue SpA, Revenio Research Oy, Revenio Australia Pty Ltd, Done Medical Oy, and Oscare Medical Oy.

In 2020, the Group's net sales totaled EUR 61.1 million, with its operating profit standing at MEUR 17.1. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Attachments: